DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Propoxyphene Napsylate and Acetaminophen (Propoxyphene Napsylate / Acetaminophen) - Summary

 
 



SUMMARY

Propoxyphene is an opioid analgesic. Acetaminophen is a non-opioid analgesic and antipyretic.

This product is indicated for the relief of mild to moderate pain, either when pain is present alone or when it is accompanied by fever.
See all Propoxyphene Napsylate and Acetaminophen indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Propoxyphene Napsylate and Acetaminophen (Propoxyphene / Acetaminophen)

Morning Report: Low Back Pain, Visceral Fat, Mammograms
Source: Medscape Family Medicine Headlines [2017.02.24]
Dr Arefa Cassoobhoy highlights some of this week's most important medical news: new ACP guidelines on low back pain, using waist/hip ratios to predict risk, and the harms of false-positive mammograms.
Medscape Internal Medicine

Mediterranean diet may decrease pain associated with obesity
Source: Nutrition / Diet News From Medical News Today [2017.02.24]
Those who eat more fish, plant proteins less likely to suffer, study finds.Eating a Mediterranean diet could decrease the chances an overweight person will experience regular pain, new research...

Itch neurons play a role in managing pain
Source: Pain / Anesthetics News From Medical News Today [2017.02.24]
There are neurons in your skin that are wired for one purpose and one purpose only: to sense itchy things.

Removing Barriers to Pain Relief in Older Adults
Source: Medscape Family Medicine Headlines [2017.02.23]
Approaches to pain have shifted from concerns about undertreatment to concerns about overprescribing. Where can we find the balance for older adults?
Medscape Nurses

An alternative to opioids? Compound from marine snail is potent pain reliever
Source: Biology / Biochemistry News From Medical News Today [2017.02.22]
A tiny snail may offer an alternative to opioids for pain relief. Scientists at the University of Utah have found a compound that blocks pain by targeting a pathway not associated with opioids.

more news >>

Published Studies Related to Propoxyphene Napsylate and Acetaminophen (Propoxyphene / Acetaminophen)

Analgesic efficacy of tramadol/acetaminophen and propoxyphene/acetaminophen for relief of postoperative wound pain. [2012]
Depain-X in acute postoperative pain... CONCLUSION: Among patients with mild to moderate postoperative wound pain,

Propoxyphene and pain management in the elderly. [2009.11]
Pain is frequently reported and often undertreated in the elderly population.Therefore, it is very important to consider alternatives to propoxyphene such as APAP, nonsteroidal anti-inflammatory drugs (rare use due to adverse effects) and other opioids, when managing elderly patients with pain.

more studies >>

Clinical Trials Related to Propoxyphene Napsylate and Acetaminophen (Propoxyphene / Acetaminophen)

Multiple-Ascending-Dose Study to Evaluate the Safety of Propoxyphene Napsylate In Healthy Adult Subjects [Terminated]

Lumbar Stenosis Outcomes Research II [Completed]
The primary objective of the proposed pilot study is to determine the efficacy of oxymorphone hydrochloride and propoxyphene/acetaminophen combination in prolonging the time to onset of pain and reducing the severity of pain associated with walking in patients with neurogenic intermittent claudication. The secondary objective is to examine the functional benefit of oxymorphone hydrochloride and propoxyphene/acetaminophen combination with respect to improvement in duration and distance of walking tolerance. The proposed study will also provide the foundation for a treadmill-based methodology for assessing the analgesic efficacy of drugs for low back pain provoked by standing and walking associated with lumbar spinal stenosis.

Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain [Completed]
RATIONALE: Oxycodone helps lessen pain caused by cancer and may improve quality of life. It is not yet known whether oxycodone works better and is more cost effective than standard therapy in treating patients with cancer pain. PURPOSE: This randomized phase IV trial is studying oxycodone to see how well it works compared with standard pain therapy in treating patients with cancer pain and if it is more cost effective than standard pain therapy.

Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression [Terminated]
Objectives of the study: Primary: Assess the ability of a continuous treatment of celecoxib 200 mg versus placebo administered once daily (QD) for 24 months in slowing disease progression as assessed radiographically in subjects with osteoarthritis (OA) of the hipSecondary: Assess the ability of a continuous treatment of celecoxib 200 mg versus placebo administered QD for 24 months in treating disease signs and symptoms in subjects with OA of the hip. Evaluate the ability of a continuous 24-month intake of celecoxib 200 mg QD versus placebo to reduce number of subjects eligible for hip replacement according to the investigator. Evaluate the tolerability and safety of a continuous 24-month intake of celecoxib 200 mg QD versus placebo in subjects with OA of the hip.

An Effectiveness and Safety Study of Two Doses of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee [Completed]
The purpose of this study is to determine the safety and effectiveness of 650 mg and 1300 mg acetaminophen extended release given three times a day for the relief of signs and symptoms of osteoarthritis of the hip or knee for a period of 12 weeks.

more trials >>

Reports of Suspected Propoxyphene Napsylate and Acetaminophen (Propoxyphene / Acetaminophen) Side Effects

Myocardial Infarction (9)Atrial Fibrillation (8)Palpitations (5)Arrhythmia (4)Blood Pressure Inadequately Controlled (3)Transient Ischaemic Attack (3)Blindness (3)Cardiac Arrest (3)Sudden Death (2)Disorientation (2)more >>


Page last updated: 2017-02-24

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015